Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,595.60
(
0.41%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
107.89
(
-0.33%
)
Bitcoin
67,448.04
(
2.26%
)
News Focus
News Focus

Replies to post #218784 on Biotech Values

Replies to #218784 on Biotech Values
icon url

DewDiligence

05/01/18 4:22 PM

#218786 RE: DewDiligence #218784

2Q18 or 3Q18 may see ABBV/ENTA overtake GILD for the #1 spot in worldwide HCV sales.
icon url

DewDiligence

05/01/18 4:58 PM

#218791 RE: DewDiligence #218784

GILD 1Q18 CC slides:

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDA0MDA5fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636607115552077789
icon url

DewDiligence

07/25/18 4:38 PM

#220192 RE: DewDiligence #218784

GILD 2Q18 results—total HCV sales $1.0B—(-5% QoQ):

http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle&ID=2359992

Full-year 2018 guidance tweaked upward due to tax rate.